Literature DB >> 22526010

[Old immune system- new information? Importance of mononuclear phagocytes in corneal allograft rejection].

T Lapp1, D Reinhold, P Maier, T Reinhard.   

Abstract

Mononuclear phagocytes are derived from bone marrow precursor cells and are part of the innate immune system. These cells circulate in the blood as monocytes but differentiate in the peripheral circulation into tissue macrophages and dendritic cells under the influence of various cytokines. In addition to antimicrobial properties, macrophages also participate in wound healing; however, they also support degenerative and inflammatory processes. In cases of acute corneal allograft rejection, mononuclear cells initially form the main component of the cellular anterior chamber infiltrate. How monocytes are recruited into the anterior chamber is currently uncertain. Furthermore, no information is available about the possible cytotoxic effects on corneal endothelial cells. Gaining insight into these mechanisms may lead to potential pharmacological interventions.

Mesh:

Year:  2012        PMID: 22526010     DOI: 10.1007/s00347-012-2584-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  49 in total

Review 1.  Ligands for natural killer cell receptors: redundancy or specificity.

Authors:  A Cerwenka; L L Lanier
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

Review 2.  Corneal immunity is mediated by heterogeneous population of antigen-presenting cells.

Authors:  Pedram Hamrah; Syed O Huq; Ying Liu; Qiang Zhang; M Reza Dana
Journal:  J Leukoc Biol       Date:  2003-08       Impact factor: 4.962

3.  CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis.

Authors:  Sushma Hegde; Clay Beauregard; Elizabeth Mayhew; Jerry Y Niederkorn
Journal:  Transplantation       Date:  2005-01-15       Impact factor: 4.939

Review 4.  [Systemic immunosuppressives after penetrating keratoplasty].

Authors:  A Reis; F Birnbaum; T Reinhard
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

5.  Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice.

Authors:  Lucia Kuffová; Magdaléna Netuková; Linda Duncan; Andrew Porter; Brigitta Stockinger; John V Forrester
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

Review 7.  Corneal antigen-presenting cells.

Authors:  Pedram Hamrah; M Reza Dana
Journal:  Chem Immunol Allergy       Date:  2007

Review 8.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

9.  Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response.

Authors:  L Kuffová; L Lumsden; V Veselá; J A Taylor; M Filipec; V Holán; A D Dick; J V Forrester
Journal:  Transplantation       Date:  2001-10-15       Impact factor: 4.939

10.  Therapeutic siRNA silencing in inflammatory monocytes in mice.

Authors:  Florian Leuschner; Partha Dutta; Rostic Gorbatov; Tatiana I Novobrantseva; Jessica S Donahoe; Gabriel Courties; Kang Mi Lee; James I Kim; James F Markmann; Brett Marinelli; Peter Panizzi; Won Woo Lee; Yoshiko Iwamoto; Stuart Milstein; Hila Epstein-Barash; William Cantley; Jamie Wong; Virna Cortez-Retamozo; Andita Newton; Kevin Love; Peter Libby; Mikael J Pittet; Filip K Swirski; Victor Koteliansky; Robert Langer; Ralph Weissleder; Daniel G Anderson; Matthias Nahrendorf
Journal:  Nat Biotechnol       Date:  2011-10-09       Impact factor: 54.908

View more
  1 in total

Review 1.  [Human leukocyte antigen (HLA) system in ophthalmology].

Authors:  T Lapp; D Reinhold; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.